Literature DB >> 1775191

Superoxide dismutase partially prevents sympathetic denervation by 6-hydroxydopamine.

A Albino-Teixeira1, I Azevedo, F Martel, W Osswald.   

Abstract

The effects of superoxide dismutase (S.O.D.) in two models of chemical denervation induced by 6-hydroxydopamine (6-OHDA) were studied. To evaluate the effects of S.O.D. on in vitro 6-OHDA-induced denervation, fragments of the lateral saphenous veins of mongrel dogs were pre-incubated in oxygenated Krebs-Henseleit solution with or without S.O.D. and then incubated under control conditions, with 6-OHDA or with 6-OHDA + S.O.D. Following the incubation period the fragments were repeatedly washed with Krebs solution and then used for determination of noradrenaline and for morphological study. 6-OHDA produced a profound depletion of noradrenaline. This depletion was significantly reduced although not prevented by S.O.D. The protective effect of S.O.D. was concentration-dependent. The ultrastructural study confirmed the 6-OHDA-induced sympathetic nerve degeneration as well as the protective effect afforded by S.O.D. In order to evaluate the effects of S.O.D. on in vivo 6-OHDA-induced denervation, male Wistar rats were anaesthetized and the tail vein cannulated. Saline or S.O.D. were intravenously delivered. 6-OHDA was injected five minutes after the beginning of infusions. Fragments of the left ventricle and vasa deferentia were used for determination of noradrenaline and for morphological study. 6-OHDA produced a significant depletion of noradrenaline in the left ventricle and vas deferens (to 8% and 18% of control values respectively). This depletion was reduced, though not prevented by S.O.D. Morphological data confirmed the neurotoxic effect of 6-OHDA and a protective role for S.O.D.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775191     DOI: 10.1007/bf00167380

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  Purine agonists prevent trophic changes caused by sympathetic denervation.

Authors:  A Albino-Teixeira; I Azevedo; D Branco; W Osswald
Journal:  Eur J Pharmacol       Date:  1990-04-10       Impact factor: 4.432

Review 2.  The pharmacology of 6-hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Annu Rev Pharmacol       Date:  1973       Impact factor: 13.820

3.  The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.

Authors:  G Cohen; R E Heikkila
Journal:  J Biol Chem       Date:  1974-04-25       Impact factor: 5.157

4.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

5.  Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.

Authors:  R E Heikkila; C Mytilineou; L Côté; G Cohen
Journal:  J Neurochem       Date:  1973-05       Impact factor: 5.372

6.  Sympathetic denervation caused by long-term noradrenaline infusions; prevention by desipramine and superoxide dismutase.

Authors:  A Albino Teixeira; I Azevedo; D Branco; E Rodrigues-Pereira; W Osswald
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl.

Authors:  T Bennett; G Burnstock; J L Cobb; T Malmfors
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

8.  Structural and functional alterations caused at the extraneuronal level by sympathetic denervation of blood vessels.

Authors:  D Branco; A A Teixeira; I Azevedo; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

9.  Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool.

Authors:  P Soares-da-Silva; R Davidson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

10.  Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids.

Authors:  S Marklund
Journal:  Acta Physiol Scand Suppl       Date:  1980
View more
  3 in total

1.  Pergolide can induce soluble superoxide dismutase in rat striata.

Authors:  A Clow; T Hussain; V Glover; M Sandler; M Walker; D Dexter
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 2.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

3.  Effects of 6-hydroxydopamine on pre- and post-junctional 5-HT1-like receptor-mediated responses in dog saphenous vein.

Authors:  A D Medhurst; G E Novotny; S G Parker; N M Deighton; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.